Increased bone marrow iron stores is an independent risk factor for invasive aspergillosis in patients with high‐risk hematologic malignancies and recipients of allogeneic hematopoietic stem cell transplantation

Invasive aspergillosis (IA) is a leading cause of death in patients with leukemia and those who have undergone hematopoietic stem cell transplantation. Laboratory studies have demonstrated that iron is essential for Aspergillus growth and virulence.

[1]  M. Moore,et al.  The Aspergillus fumigatus Siderophore Biosynthetic Gene sidA, Encoding l-Ornithine N5-Oxygenase, Is Required for Virulence , 2005, Infection and Immunity.

[2]  P. Vandenberghe,et al.  Mucormycosis in allogeneic bone marrow transplant recipients: report of five cases and review of the role of iron overload in the pathogenesis , 1999, Bone Marrow Transplantation.

[3]  L. Bertoli,et al.  Transfusion iron overload in adults with acute leukemia: manifestations and therapy. , 2000, The American journal of the medical sciences.

[4]  J. Briones,et al.  Iron overload might increase transplant-related mortality in haematopoietic stem cell transplantation , 2002, Bone Marrow Transplantation.

[5]  J. Briones,et al.  Frequent severe liver iron overload after stem cell transplantation and its possible association with invasive aspergillosis , 2004, Bone Marrow Transplantation.

[6]  E. Weinberg.  Iron, infection, and neoplasia. , 1986, Clinical physiology and biochemistry.

[7]  R. Fischer.  The oral chelator deferasirox--a new perspective for patients with iron overload. , 2006, Haematologica.

[8]  Russell E. Lewis,et al.  Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases. , 2005, The Journal of infectious diseases.

[9]  D. Weatherall,et al.  Iron and infection. , 1996 .

[10]  J. S. San Miguel,et al.  Iron metabolism and fungal infections in patients with haematological malignancies. , 1995, Journal of clinical pathology.

[11]  D. Denning,et al.  Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  Weinberg Ed.  Iron, infection, and neoplasia. , 1986 .

[13]  J. Karp,et al.  Association of reduced total iron binding capacity and fungal infections in leukemic granulocytopenic patients. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  M. Boeckh,et al.  Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. , 2002, Blood.

[15]  Brigden Ml.  Clinical utility of serum tests for iron deficiency in hospitalized patients. , 1990 .

[16]  B. Barlogie,et al.  Iron overload is a major risk factor for severe infection after autologous stem cell transplantation: a study of 367 myeloma patients , 2006, Bone Marrow Transplantation.

[17]  V. Fuster.  Role of platelets in the development of atherosclerotic disease and possible interference with platelet inhibitor drugs. , 2009, Scandinavian journal of haematology. Supplementum.

[18]  H. Takkunen.  Iron deficiency in the Finnish adult population. , 1976, Scandinavian journal of haematology. Supplementum.

[19]  D. Kontoyiannis,et al.  Invasive Aspergillosis in 2002: An Update , 2002, European Journal of Clinical Microbiology and Infectious Diseases.

[20]  B. Wenz,et al.  Clinical utility of serum tests for iron deficiency in hospitalized patients. , 1990, American journal of clinical pathology.

[21]  S. Strasser,et al.  Iron overload in bone marrow transplant recipients , 1998, Bone Marrow Transplantation.